NuCana
NCNA
#10572
Rank
HK$4.26 M
Marketcap
HK$0.69
Share price
-2.21%
Change (1 day)
-99.96%
Change (1 year)

P/E ratio for NuCana (NCNA)

P/E ratio as of December 2025 (TTM): -0.0001

According to NuCana 's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is -0.000134067. At the end of 2024 the company had a P/E ratio of -0.1720.

P/E ratio history for NuCana from 2018 to 2025

PE ratio at the end of each year

Year P/E ratio Change
2024-0.1720
2022-0.8842-60.99%
2021-2.27-48.44%
2020-4.40-37.93%
2019-7.08-71.79%
2018-25.1

P/E ratio for similar companies or competitors

Company P/E ratio P/E ratio differencediff. Country
ORIC Pharmaceuticals
ORIC
-6.58 4,910,743.09%๐Ÿ‡บ๐Ÿ‡ธ USA

How to read a P/E ratio?

The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.

Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.